GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » Operating Margin %

Marrone Bio Innovations (Marrone Bio Innovations) Operating Margin % : -63.28% (As of Mar. 2022)


View and export this data going back to 2013. Start your Free Trial

What is Marrone Bio Innovations Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Marrone Bio Innovations's Operating Income for the three months ended in Mar. 2022 was $-7.02 Mil. Marrone Bio Innovations's Revenue for the three months ended in Mar. 2022 was $11.10 Mil. Therefore, Marrone Bio Innovations's Operating Margin % for the quarter that ended in Mar. 2022 was -63.28%.

Good Sign:

Marrone Bio Innovations Inc operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Marrone Bio Innovations's Operating Margin % or its related term are showing as below:

MBII' s Operating Margin % Range Over the Past 10 Years
Min: -531.23   Med: -147.54   Max: -34.76
Current: -43.72


MBII's Operating Margin % is not ranked
in the Agriculture industry.
Industry Median: 5.455 vs MBII: -43.72

Marrone Bio Innovations's 5-Year Average Operating Margin % Growth Rate was 26.90% per year.

Marrone Bio Innovations's Operating Income for the three months ended in Mar. 2022 was $-7.02 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2022 was $-19.40 Mil.

Warning Sign:

Marrone Bio Innovations Inc has never been profitable in the past 3 years. It lost money every year.


Marrone Bio Innovations Operating Margin % Historical Data

The historical data trend for Marrone Bio Innovations's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marrone Bio Innovations Operating Margin % Chart

Marrone Bio Innovations Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -126.58 -91.91 -95.27 -44.81 -34.76

Marrone Bio Innovations Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.41 -18.70 -44.72 -51.89 -63.28

Competitive Comparison of Marrone Bio Innovations's Operating Margin %

For the Agricultural Inputs subindustry, Marrone Bio Innovations's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marrone Bio Innovations's Operating Margin % Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Marrone Bio Innovations's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Marrone Bio Innovations's Operating Margin % falls into.



Marrone Bio Innovations Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Marrone Bio Innovations's Operating Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Operating Margin %=Operating Income (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=-15.404 / 44.31
=-34.76 %

Marrone Bio Innovations's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=-7.022 / 11.097
=-63.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marrone Bio Innovations  (NAS:MBII) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Marrone Bio Innovations Operating Margin % Related Terms

Thank you for viewing the detailed overview of Marrone Bio Innovations's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marrone Bio Innovations (Marrone Bio Innovations) Business Description

Traded in Other Exchanges
N/A
Address
7780-420 Brier Creek Parkway,, Raleigh, NC, USA, 27617
Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.
Executives
Pamela G Marrone director, officer: CEO and President C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, A-107, DAVIS CA 95618
Ladon Johnson officer: Interim CFO C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARWAY RALEIGH NC 27617-7882
Ardsley Ridgecrest Partners Fund, L.p. other: See Footnote (1) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Suping (sue) Cheung officer: Chief Financial Officer C/O QUICKLOGIC CORPORATION, SUNNYVALE CA 94089
Matti Tiainen officer: SVP, International Sales C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Lara L Lee director C/O MARRONE BIO INNOVATIONS, INC., 1540 DREW AVENUE, DAVIS CA 95618
Kevin Helash director, officer: Chief Executive Officer C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Ardsley Advisory Partners Gp Llc other: See Footnotes(1)(2) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Ospraie Management, Llc director, 10 percent owner, other: (See Remarks) 437 MADISON AVENUE, 28TH FLOOR, NEW YORK NY 10022
Ospraie Management, Inc. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ospraie Holding I, L.p. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Dwight Anderson director, 10 percent owner, other: (See Remarks) C/O OSPRAIE MANAGEMENT, LLC, 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ardsley Healthcare Fund, L.p. other: See Footnote (1) C/O ARDSLEY PARTNERS I GP, LLC, 262 HARBOR DRIVE, STAMFORD CT 06902
Ospraie Ag Science Llc director, 10 percent owner, other: (See Remarks) C/O DWIGHT ANDERSON 437 MADISON AVENUE, 28TH FLOOR NEW YORK NY 10022
Van Herk Investments B.v. 10 percent owner LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME